Vertex Pharmaceuticals Inc (VRTX) Stock Rating

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for serious diseases. Its main products are the cystic fibrosis therapies Kalydeco, Orkambi, Symdeko, Trikafta/Kaftrio, and Alyftrek, where its treatments remain the global standard of care. It has broadened its portfolio with Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid medication for moderate-to-severe acute pain in adults.

Rating as of 2026-07-07. Live price updates in real time.